Online citations, reference lists, and bibliographies.
← Back to Search

Non-Hodgkin Lymphoma In The Far East: Review Of 730 Cases From The International Non-Hodgkin Lymphoma Classification Project

A. Perry, J. Diebold, B. Nathwani, K. Maclennan, H. Müller-Hermelink, M. Bast, E. Boilesen, J. Armitage, D. Weisenburger
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Large and systematic studies of non-Hodgkin lymphoma (NHL) in the Far East (FE) with good comparative data are scarce in the literature. In this study, five expert hematopathologists classified 730 consecutive cases of newly-diagnosed NHL from four sites in the FE (excluding Japan) using the World Health Organization classification. The results were compared to 399 cases from North America (NA). We found a significantly higher male to female ratio in the FE compared to NA (1.7 versus 1.1; p < 0.05). The median ages of patients with low-grade (LG) and high-grade (HG) B-NHL in the FE (58 and 51 years, respectively) were significantly lower than in NA (64 and 68 years, respectively). The FE had a significantly lower relative frequency of B-NHL and a higher frequency of T-NHL (82 vs. 18 %) compared to NA (90.5 vs. 9.5 %). Among mature B cell lymphomas, the FE had a significantly higher relative frequency of HG B-NHL (54.8 %) and a lower frequency of LG B-NHL (27.2 %) than NA (34.3 and 56.1 %, respectively). Diffuse large B cell lymphoma was more common in the FE (49.4 %) compared to NA (29.3 %), whereas the relative frequency of follicular lymphoma was lower in the FE (9.4 %) compared to NA (33.6 %). Among T-NHL, nasal NK/T cell NHL was more frequent in the FE (5.2 %) compared to NA (0 %). Peripheral T cell lymphoma was also more common in the FE (9.1 %) than in NA (5.3 %). Further epidemiologic studies are needed to better understand the pathobiology of these differences.
This paper references
10.1002/1097-0142(19951001)76:7<1245::AID-CNCR2820760723>3.0.CO;2-D
The investigation of epstein–barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic correlations
Nayera Anwar (1995)
10.1016/S0046-8177(97)90055-1
The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
C. Cool (1997)
A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project
J. R. Anderson (1997)
10.1159/000011831
Plasmacytoma of the Gastrointestinal Tract in Korea: Higher Incidence than in Japan and Epstein-Barr Virus Association
Y. Tomita (1997)
10.1023/A:1008265532487
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.
J. Anderson (1998)
10.1046/j.1440-1827.2000.01108.x
The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities
*Lymphoma Study Group of Japanese Pathologists (2000)
10.1080/028418601750444231
Pattern of malignant lymphoma in the United Arab Emirates--a histopathologic and immunologic study in 208 native patients.
A. Castella (2001)
2001)World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues
ES Jaffe (2001)
10.1007/BF00051298
The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants
L. Herrinton (2004)
Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies.
N. Almasri (2004)
10.1016/J.HUMPATH.2003.10.007
Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification.
S. Sukpanichnant (2004)
10.1023/A:1020608328969
Incidence of leukemia in Asian migrants to the United States and their descendants
J. Pang (2004)
10.1111/j.1365-2141.2005.05387.x
Incidence and spectrum of non‐Hodgkin lymphoma in Chinese migrants to British Columbia
W. Au (2005)
10.1093/CARCIN/BGI212
Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case-control study.
A. Cross (2006)
10.1182/BLOOD-2005-06-2508
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
L. Morton (2006)
10.1002/AJH.20649
Clinicopathological analysis of 598 malignant lymphomas in Taiwan: Seven‐year experience in a single institution
Ming-Yuan Lee (2006)
10.1002/ijc.22719
The non‐Hodgkin lymphomas: A review of the epidemiologic literature
D. Alexander (2007)
10.1111/j.1751-2980.2008.00344.x
Changing epidemiology of Helicobacter pylori in Asia
H. J. Tan (2008)
10.1200/JCO.2008.16.4558
International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
J. Vose (2008)
10.1007/s12185-008-0132-1
A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China
S. Gross (2008)
International T-Cell Lymphoma Project (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes
J Vose (2008)
World Health Organization classification of tumours of haematopoietic and lymphoid tissues
SH Swerdlow (2008)
10.1007/s00277-009-0870-z
The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan
Wei-Liang Chen (2009)
10.1007/s10552-009-9316-0
Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes
L. Goldman (2009)
10.1007/s00277-009-0801-z
Frequencies of non-Hodgkin’s lymphoma subtypes in Kuwait: comparisons between different ethnic groups
Reem M. Ameen (2009)
10.1002/ajh.21824
Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification
S. Yoon (2010)
10.3109/10428194.2011.584254
Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system
A. Perry (2011)
10.4103/0019-509X.92276
Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.
R. T. Yaqo (2011)
10.1016/j.canep.2010.09.009
Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran.
Z. Mozaheb (2011)
10.1186/1746-1596-6-77
Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution
Qun-pei Yang (2011)
10.1309/AJCP7YLTQPUSDQ5C
Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification.
J. Sun (2012)
Prevalence and spectrum of head and neck lymphomas at Tygerberg Hospital, South Africa, 2003 to 2007.
M. Chetty (2012)
10.1182/blood-2012-07-440073
Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.
J. Laurini (2012)
10.1007/s10552-012-0047-2
Meat intake and risk of non-Hodgkin lymphoma
B. Aschebrook-Kilfoy (2012)
10.1093/carcin/bgs315
Phytanic acid and the risk of non-Hodgkin lymphoma.
N. Ollberding (2013)
10.1186/1471-230X-13-104
Prevalence and risk factors of Helicobacter pylori infection in Korea: Nationwide multicenter study over 13 years
S. H. Lim (2013)
10.1007/s12253-013-9634-0
A Collaborative Nationwide Lymphoma Study in Lebanon: Incidence of Various Subtypes and Analysis of Associations with Viruses
Z. Otrock (2013)
10.1002/ijc.28849
Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006
M. Leeuwen (2014)
10.3109/10428194.2013.831849
Hematopathologic discrepancies between referral and review diagnoses: a gap between general pathologists and hematopathologists
C. Chang (2014)
10.1007/978-3-319-13150-4_1
Epidemiology and etiology of non-hodgkin lymphoma.
B. Chiu (2015)
distributions of the major subtypes differ by geographic locations
JR Anderson (2016)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
S. Swerdlow (2017)
10.1891/9781617052828.0023
Non-Hodgkin Lymphoma and Hodgkin Lymphoma
C. Owens (2017)



This paper is referenced by
10.3389/fonc.2021.675353
Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma
P. S. de Carvalho (2021)
10.3389/fonc.2020.00473
The Value of CEUS in Distinguishing Cancerous Lymph Nodes From the Primary Lymphoma of the Head and Neck
J. Nie (2020)
10.1038/s41568-020-0247-0
Peripheral T cell lymphomas: from the bench to the clinic
D. Fiore (2020)
10.23937/2378-3419/1410140
Retrospective Lymphoma Study from Malaysia Private Hospital
S. Abdul (2020)
10.2478/amma-2019-0005
The Influence of GPX1 Pro198Leu, CAT C262T and MnSOD Ala16Val Gene Polymorphisms on Susceptibility for Non-Hodgkin Lymphoma and Overall Survival Rate at Five Years from Diagnosis
Adriana-Stela Cosma (2019)
10.4143/crt.2018.010
Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy
Y. Zhang (2019)
10.1002/hon.2687
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma
Kitsada Wudhikarn (2019)
10.1007/978-3-319-99716-2_2
Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma.
J. Iqbal (2019)
10.3329/BIRDEM.V8I3.38126
Histo-morphologic Spectrum of Non-Hodgkin Lymphoma According to WHO Classification 2016: A Cross-Sectional Study
Shamoli Yasmin (2018)
10.1002/hon.2392
Non‐Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand
T. Intragumtornchai (2018)
Histological type distribution and expression of nm23, VEGF, TOP2A and MUM-1 in peripheral T-cell and NK-cell lymphomas in Chinese: analysis of 313 cases.
Wenting Huang (2018)
10.3906/sag-1804-107
Distribution of lymphomas in Turkey: data of 4239 cases from a single institution using the WHO classification
A. Sağlam (2018)
10.1136/bcr-2017-223637
Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin’s lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy
Fayez Hanna (2018)
10.1097/MD.0000000000012120
Epidemiologic characteristics of malignant lymphoma in Hubei, China
Jingshu Meng (2018)
10.1007/s12308-018-0336-0
Distribution of lymphomas in Mexico: a multicenter descriptive study
Adrián Carballo-Zarate (2018)
10.7150/jca.24384
Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma
Y. Wang (2018)
10.1007/s11899-018-0460-z
Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review
W. Lone (2018)
10.1016/j.ejrad.2017.12.001
Value of contrast-enhanced ultrasound and PET/CT in assessment of extramedullary lymphoma.
W. Jiang (2018)
10.1016/j.hoc.2016.11.007
Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
S. Makita (2017)
10.1007/s11282-017-0309-5
Extranodal lymphoma arising within the maxillary alveolus: a systematic review
D. Macdonald (2017)
10.1007/s11912-017-0582-9
Genetic Landscape and Classification of Peripheral T Cell Lymphomas
Rosalind F. Sandell (2017)
10.3324/haematol.2016.148809
Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
Anamarija M Perry (2016)
10.1007/s11899-016-0353-y
T-cell Lymphoma Epidemiology: the Known and Unknown
Anh Phan (2016)
Clinical factors and outcome in T-cell lymphoma: a population-based perspective
F. Ellin (2016)
Semantic Scholar Logo Some data provided by SemanticScholar